A5001812410- Schizophrenia research and treatment
- Pharmaceutical Practices and Patient Outcomes
- Blood disorders and treatments
- Pharmacy and Medical Practices
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices
- Healthcare Decision-Making and Restraints
- Health Sciences Research and Education
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Homelessness and Social Issues
- Global Health Workforce Issues
- Safety Systems Engineering in Autonomy
- Information and Cyber Security
- Traumatic Brain Injury Research
- Athletic Training and Education
- Neutropenia and Cancer Infections
- Nephrotoxicity and Medicinal Plants
- Pharmacovigilance and Adverse Drug Reactions
- Infectious Diseases and Tuberculosis
- scientometrics and bibliometrics research
- Potassium and Related Disorders
- Patient Satisfaction in Healthcare
- Healthcare Systems and Technology
- Medication Adherence and Compliance
Baystate Medical Center
2021-2024
Mercy Hospital Springfield
2021-2023
ORCID
2023
University of Maryland, Baltimore
2016-2022
Jersey City Medical Center
2022
University of Hawaiʻi at Mānoa
2017
University of Arizona
2012-2014
Kingsbrook Jewish Medical Center
2013-2014
Johns Hopkins University
2006
Nonadherence to antipsychotic medications for the treatment of schizophrenia is a widely recognized concern, leading poorer clinical outcomes and higher costs. Long-acting injectable (LAI) antipsychotics offer an extended dosing interval option patients, although current options may require oral overlap at initiation. Aripiprazole lauroxil LAI that offers multiple but requires during initiation first 21 consecutive days. As alternative overlap, novel nano-crystalline milled dispersion...
To determine if clozapine can be safely utilized in psychiatric patients with benign neutropenia.A single-center, retrospective chart review study of records from 2001 to 2014 was conducted an inpatient hospital. Patients included had neutropenia prior receiving and received using modified monitoring guidelines. All available laboratory values for absolute neutrophil count (ANC) before initiation during treatment were evaluated. The primary endpoint difference ANC after clozapine.A total 26...
The Mental Health Clinician (MHC) continues to be a valuable resource for psychiatric practitioners and researchers with over 1 million article views in 2023. quality work of authors, reviewers the editorial board is reflected by MHC indexing PubMed, Scopus, Google Scholar, DOAJ. greatly appreciates everyone who submitted manuscript or peer review 2023 would like acknowledge those whose contributions have been exceptional.The Editors' Choice Award Outstanding Articles identifies manuscripts...
One of clozapine's unrecognized potential side effects is renal insufficiency and nephritis. Although most clinicians are aware the possibility clozapine-induced myocarditis, less known about other inflammatory disorders due to clozapine treatment. This patient was started on lithium within 4 days each although discontinued after 7 tremor. Routine labs showed an increase in serum creatinine, which initially attributed recent lithium. However, patient's kidney function continued worsen,...
Clozapine levels can be influenced by many factors, including pharmacogenomic variability, pharmacokinetic drug interactions, and infection/inflammation. The concentration-to-dose ratio (C/D), a measure of medication's rate metabolism clearance, may increase during an acute infection due to decreased medication clearance.A 56-year-old White man was restarted on clozapine titrated up 350 mg/d with therapeutic steady-state (C/D 1.11) hospital day (HD) 69. At this time, he also being treated...
Patients with psychiatric disorders have high rates of medication nonadherence. Though there are many factors that contribute to nonadherence, lack patient understanding about how manage medication-related problems when they occur is associated discontinuation. This article describes the importance teaching patients solve and discusses scientific evaluation such a practice.
Davis, Erica A.K. PharmD, BCPS, BCPP; Batongbakal, Leo T. BCPP Author Information
The Mental Health Clinician (MHC) continues to be a valuable resource for psychiatric practitioners and researchers with nearly 1 million article views in 2022. MHC is now indexed PubMed, Scopus, DOAJ which reflects the quality of our authors, reviewers, editorial board. board very appreciative everyone who submitted manuscript or authored peer review 2022 would like acknowledge those whose contributions have been exceptionally significant.The Editors' Choice Award Outstanding Articles...
Abstract Background Several different formulations of valproic acid derivatives are available in the United States. Although these have absorption characteristics, they believed to be interchangeable, with exception extended-release product. Case Report A 31-year-old African American man schizoaffective disorder was started on fluphenazine concentrate and valproate oral solution admission an inpatient unit. 12-hour steady-state concentration, drawn 1000 mg/day, resulted 40.8 mg/L, dose...
Peer comparison is a behavioral strategy that provides feedback to individuals on how they compare with others. It used improve health care quality, reduce inappropriate prescribing, and physician performance. There very little data peer the impact system-wide prescribing practices, particularly antipsychotics. To end, Maryland statewide pharmacy therapeutics committee reviews hospital-level antipsychotic for 5 facilities quarterly basis, including high doses polypharmacy. One facility,...
The Mental Health Clinician (MHC) has made a significant impact on the psychopharmacology literature, with nearly 1 million article views in 2021. This is direct result of those who have either submitted manuscript to MHC or authored peer review. editorial board extremely grateful for all our authors and reviewers would like specifically recognize some whose contributions been especially noteworthy.The Editors' Choice Award Outstanding Articles recognizes manuscripts that were particular...
Abstract We present a case in which patient developed fever and leukocytosis subsequent to each monthly haloperidol decanoate injection, an adverse reaction that does not meet the diagnostic criteria of neuroleptic malignant syndrome (NMS) or any previously reported for this medication. A being treated with psychosis experienced within 3 days injection along swelling, pain, “knot” feeling at site. This recurred after several months. Muscle rigidity changes vital signs other than temperature...